Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128a1 · Date: 20241120 · State: PR
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
114,910
Total Claims
$5.3M
Drug Cost
2,426
Beneficiaries
$2,202
Cost/Patient
Risk Score Breakdown 49/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-67%
Opioid rate vs peers
0.7% vs 2.2% avg
+56%
Cost per patient vs peers
$2,202 vs $1,411 avg
-5%
Brand preference vs peers
10.1% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.7%
Opioid Rate
836
Opioid Claims
$12K
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 11,468 claims · $4.1M
Generic: 101,797 claims · $1.2M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 893 | $407K |
| Dulaglutide | 356 | $352K |
| Sitagliptin Phosphate | 480 | $295K |
| Apixaban | 514 | $293K |
| Dapagliflozin Propanediol | 488 | $291K |
| Sitagliptin Phos/Metformin Hcl | 496 | $266K |
| Insulin Lispro | 620 | $249K |
| Empagliflozin | 294 | $195K |
| Insulin Nph Hum/Reg Insulin Hm | 398 | $139K |
| Rivaroxaban | 219 | $120K |
| Tiotropium Bromide | 212 | $112K |
| Budesonide/Formoterol Fumarate | 262 | $104K |
| Levothyroxine Sodium | 1,353 | $69K |
| Tiotropium Br/Olodaterol Hcl | 127 | $61K |
| Insulin Glargine,hum.Rec.Anlog | 106 | $55K |
Prescribing Profile
Patient Profile
74
Avg Age
55%
Female
2.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About